SEC Form 4 · accession 0001209191-18-022180
GLOBUS MEDICAL INC · GMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Schwartz
Officer — Senior VP and General Counsel
Period of report
Mar 28, 2018
Accepted (ET)
Mar 30, 2018 · 11:40 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001237831
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Mar 28, 2018 | M | 24,000 | $24.98 | A | 24,000 | D | |
| Class A Common Stock | Mar 28, 2018 | S | 24,000 | $50.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F2 | $24.98 | Mar 28, 2018 | M | 24,000 | D | — | Apr 28, 2026 | Class A Common Stock | 24,000 | 51,000 | D |
Explanation of responses
- F1This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on February 26, 2018, which is intended to comply with Rule 10b5-1.
- F2These options were granted on May 3, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on April 28, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.